Koyfin Home > Directory > Health Care > Arcus Biosciences Inc > Long-Term Investments

Arcus Biosciences Inc Long-Term Investments Chart (RCUS)

Arcus Biosciences Inc annual/quarterly Long-Term Investments from 2017 to 2018.
  • Arcus Biosciences Inc Long-Term Investments for the quarter ending December 12, 2018 was $4m a -153.48% decrease of -7m year over year
  • Arcus Biosciences Inc Long-Term Investments for the last 12 months ending December 12, 2018 was $4m a -153.48% decrease of -7m year over year
  • Arcus Biosciences Inc Annual Long-Term Investments for 2018 was $4m a 84.44% increase of 4m from 2017
  • Arcus Biosciences Inc Annual Long-Term Investments for 2017 was $1m a -46.63% decrease of 0m from 2016
  • Arcus Biosciences Inc Annual Long-Term Investments for 2016 was $1m
Other Cash Flow Metrics:
  • Arcus Biosciences Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $-7m a -86.39% increase of 6m year over year
  • Arcus Biosciences Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-5m
  • Arcus Biosciences Inc Total Revenue for the quarter ending December 12, 2018 was $2m a 19.97% increase of 0m year over year
View Chart On Koyfin

Quarterly RCUS Long-Term Investments Data

12/2018$4m
09/2018$9m
06/2018$14m
03/2018$11m
12/2017$1m

Annual RCUS Long-Term Investments Data

2018$4m
2017$1m
2016$1m